Pregnancy Outcome Data and Blood Samples for Preeclampsia Screening

This study aims to gather important data from pregnant women who are expecting one baby and are being screened for pre-eclampsia, a pregnancy complication. This screening takes place between the 11th and 14th weeks of pregnancy. By collecting blood samples and medical history, this research seeks to validate a new test called the Labcorp Preeclampsia ScreenTM assay. The goal is to improve the ability to predict early, preterm, and term pre-eclampsia, potentially leading to better care and monitoring for pregnant women. Participants in the study will provide blood samples and share their pregnancy outcomes and medical history. These blood samples will be analyzed to see how well the Labcorp test can predict the risk of developing pre-eclampsia before 34 weeks or before 37 weeks of pregnancy. The performance of this test is then compared to actual pregnancy outcomes to assess its accuracy. This research could lead to the development of more effective and timely screenings for pre-eclampsia, ultimately improving health outcomes for mothers and their babies.